180 related articles for article (PubMed ID: 11469912)
21. Lexipafant inhibits postsurgical adhesion formation.
Ozgün H; Cevikel MH; Kozaci LD; Sakarya S
J Surg Res; 2002 Apr; 103(2):141-5. PubMed ID: 11922727
[TBL] [Abstract][Full Text] [Related]
22. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.
Liu Q; Djuricin G; Rossi H; Bewsey K; Nathan C; Gattuso P; Weinstein RA; Prinz RA
Am Surg; 1999 Jul; 65(7):611-6; discussion 617. PubMed ID: 10399968
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the beneficial effect of hypertonic saline solution in acute pancreatitis.
Coelho AM; Jukemura J; Sampietre SN; Martins JO; Molan NA; Patzina RA; Lindkvist B; Jancar S; Cunha JE; D'Albuquerque LA; Machado MC
Shock; 2010 Nov; 34(5):502-7. PubMed ID: 20351627
[TBL] [Abstract][Full Text] [Related]
24. The effect of activated protein C on experimental acute necrotizing pancreatitis.
Yamanel L; Mas MR; Comert B; Isik AT; Aydin S; Mas N; Deveci S; Ozyurt M; Tasci I; Unal T
Crit Care; 2005 Jun; 9(3):R184-90. PubMed ID: 15987389
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor.
Kingsnorth AN
Scand J Gastroenterol Suppl; 1996; 219():28-31. PubMed ID: 8865468
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.
Yagci G; Gul H; Simsek A; Buyukdogan V; Onguru O; Zeybek N; Aydin A; Balkan M; Yildiz O; Sen D
J Gastroenterol; 2004; 39(3):268-76. PubMed ID: 15065005
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
Kingsnorth AN; Galloway SW; Formela LJ
Br J Surg; 1995 Oct; 82(10):1414-20. PubMed ID: 7489182
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis.
Balachandra S; Genovese T; Mazzon E; Di Paola R; Thiemerman C; Siriwardena AK; Cuzzocrea S
Surgery; 2005 Nov; 138(5):913-23. PubMed ID: 16291393
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic role of myeloperoxidase in acute pancreatitis.
Chooklin S; Pereyaslov A; Bihalskyy I
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):627-31. PubMed ID: 20007081
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effects of human interleukin 10 gene transfer on severe acute pancreatitis in rats, an experimental study].
Wang D; Jin D; Wu Z; Zou W; Xu D; Zheng Z; Liu X
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):844-7. PubMed ID: 12126536
[TBL] [Abstract][Full Text] [Related]
31. Lung changes and cytokine levels in a model of experimental acute pancreatitis.
Mozo G; del Olmo ML; Caro-Patón A; Reyes E; Manzano L; Belmonte A; Alvarez-Mon M
Rev Esp Enferm Dig; 2002 Feb; 94(2):53-66. PubMed ID: 12185654
[TBL] [Abstract][Full Text] [Related]
32. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
[TBL] [Abstract][Full Text] [Related]
33. Low dose dopamine prevents end organ damage in experimentally induced pancreatitis.
Kaya E; Arslan A; Aliyazicioglu Y; Güven H; Aydin O; Ozkan K
Hepatogastroenterology; 2005; 52(64):1250-4. PubMed ID: 16001673
[TBL] [Abstract][Full Text] [Related]
34. The use of lexipafant in the treatment of acute pancreatitis.
McKay C; Curran FJ; Sharples CE; Young CA; Baxter JN; Imrie CW
Adv Exp Med Biol; 1996; 416():365-70. PubMed ID: 9131175
[TBL] [Abstract][Full Text] [Related]
35. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.
Sun Z; Olanders K; Lasson A; Dib M; Annborn M; Andersson K; Wang X; Andersson R
J Surg Res; 2002 Jun; 105(2):220-33. PubMed ID: 12121711
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.
Mota R; Sánchez-Bueno F; Berenguer-Pina JJ; Hernández-Espinosa D; Parrilla P; Yélamos J
Br J Pharmacol; 2007 Aug; 151(7):998-1005. PubMed ID: 17533414
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
[TBL] [Abstract][Full Text] [Related]
38. Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis.
Gulcubuk A; Altunatmaz K; Sonmez K; Haktanir-Yatkin D; Uzun H; Gurel A; Aydin S
J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):49-54. PubMed ID: 16411910
[TBL] [Abstract][Full Text] [Related]
39. [Study on acute pancreatitis-associated lung injury induced by L-arginine in mice].
Zhao QL; Huang CY; Huang Y; Wang JF; Liu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):839-42. PubMed ID: 15573769
[TBL] [Abstract][Full Text] [Related]
40. Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis.
Gultekin FA; Kerem M; Tatlicioglu E; Aricioglu A; Unsal C; Bukan N
World J Gastroenterol; 2007 Jun; 13(21):2932-8. PubMed ID: 17589942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
